Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-13-023187)

Filing Details

Accession Number:: 0001225208-13-023187
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-11-08 17:50:08
Reporting Period:: 2013-11-08

Filing Date:: 2013-11-08
Accepted Time:: 2013-11-08 17:50:08
Original Submission Date:: 2013-11-08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
810509	Navidea Biopharmaceuticals Inc.	NAVB	In Vitro & In Vivo Diagnostic Substances (2835)	311080091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236444	A Brendan Ford	425 Metro Place North Suite 450 Dublin OH 43017		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-11-08	20,000	$1.45	139,250	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $1.43 to $1.45. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.